WOBURN, Mass., May 31, 2012 — CBI has released their interactive agenda for Access World, July 18-20 in Philadelphia. Access World convenes participants from the annual congresses on Rare Disease, Access Programs for Investigational and Pre-launch Drugs and Product Launch and Market Access for shared networking and tailored content.
Attendee benefits include:
- Direct interaction with regulators during FDA addresses
- Case studies from more than a dozen companies
- Shared breaks, luncheons and cocktail receptions
CBI's Access World is the leading resource for pharmaceutical executives involved in Managed Markets, HEOR, Clinical and Scientific Affairs, Pricing and Reimbursement, Patient Advocacy, Regulatory Compliance and Commercialization.
For more information about the conference, visit http://www.cbinet.com/raredisease, http://www.cbinet.com/launch or http://www.cbinet.com/accessprograms.
Contact: Kristina Weljkovic
Phone number: 339-298-2285
Email address: Email
# # #